Fospropofol Disodium

磷丙泊酚二钠

Report date: 2025/06/11 13:56:51
NME

Base Information

Drug NameFospropofol Disodium
Drug Alias Name磷酸丙泊酚fospropofolum磷丙泊福钠磷丙泊酚钠Lusedra +[9] 
ClassificationSmall molecules
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSedationPharmaceutical aidsColonic Polyps +[7] 
Global Approved IndicationsSedationAnesthesia
Approved Indications in ChinaAnesthesia
Original Approved Country/TerritoryUnited States
Original Approved Date2008/12/12
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEisai Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesYichang Humanwell Pharmaceutical Co Ltd
Inactive CompaniesEisai IncWest China Hospital Of Sichuan University
Active IndicationsSedationAnesthesia
Inactive IndicationsPharmaceutical aidsColonic PolypsCoronary Artery Disease +[5] 

Other Information

ATC CodeN01AX10
Related LinksWikipediaDrugBankKEGG